Companies: 10,795·Total market cap: $144.5T
Syneos Health, Inc.

Syneos Health, Inc.

SYNHNASDAQHealthcare
$42.98
+$0.01(+0.02%)
Market Cap$4.5B
P/E Ratio
52W High$52.23
52W Low$22.894

Syneos Health, Inc. (SYNH) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

synh · stock forecast · 24 analysts (3M) · FMP · updated Sep 30, 2024

Analyst Rating & Consensus

Based on 24 Wall Street analysts in the past 3 months

SellBuy

Buy

24 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
12
Hold
11
Sell
1
Strong Sell
0
Total: 24 · Buy rate: 50.0%

12-Month Price Target

High

$105

Consensus

$72.00

+67.5% upside

Low

$25.00

Median: $77.5 · Last Close: $42.98

The Syneos Health, Inc. (SYNH) analyst consensus is Buy, based on ratings from 24 Wall Street analysts over the past 3 months. The average 12-month SYNH price target is $72.00, representing +67.5% upside from the current price of $42.98.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $72 (67.5%)

Consensus Target

$72.00

67.5% upside

High Target

$105

144.3%

Low Target

$25

-41.8%

Current Price

$42.98

as of today

Based on analyst price targets, the SYNH stock price prediction for the next 12 months ranges from $25 to $105. The consensus SYNH price forecast of $72.00 implies 67.5% upside from the current price of $42.98.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$42.960.05%

1-day model range: $42.95–$42.97. Peak: $42.97 (-0.05%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$44+1.4%
2028$44+2.2%
2029$44+2.7%
2030$44+3.1%
2031+3.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

86%0%14%
12Buy
0Neutral
2Sell
RSI (14)72.9Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · SYNH · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$42.94BUY
MA 10$42.86BUY
MA 20$42.80BUY
MA 50$42.63BUY
MA 100$42.22BUY
MA 200$39.49BUY
Current $SYNH · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$42.94BUY
EMA 10$42.88BUY
EMA 20$42.80BUY
EMA 50$42.54BUY
EMA 100$41.98BUY
EMA 200$43.49SELL
Current $SYNH · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Mizuho2023-05-16
Maintains
NeutralNeutral
Mizuho2023-05-15
Maintains
NeutralNeutral
Baird2023-05-11
Downgrade ↓
OutperformNeutral
Barclays2023-05-11
Upgrade ↑
UnderweightEqual Weight
Deutsche Bank2023-05-11
Downgrade ↓
BuyHold
Barclays2023-05-10
Upgrade ↑
UnderweightEqual Weight
Deutsche Bank2023-05-10
Downgrade ↓
BuyHold
Baird2023-05-10
Downgrade ↓
OutperformNeutral
Barclays2023-04-04
Maintains
UnderweightUnderweight
Barclays2023-04-03
Maintains
UnderweightUnderweight

Wall Street analysts have recently issued updated ratings on Syneos Health, Inc. (SYNH) stock. Of the recent 167 rating actions, 17 were upgrades and 25 were downgrades. 24 analysts currently cover SYNH.

Analyst Recommendation Trends

Buy ratings00
Hold ratings28↑ +6
Sell ratings00

SYNH analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

Revenue Next Year

EPS This Year

EPS Next Year

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast SYNH EPS of $ for the current fiscal year, based on estimates from 0 analysts. The SYNH revenue forecast is for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The SYNH stock forecast is supported by two independent data sources: analyst consensus ratings from 24 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SYNH price target is $72.00 (+67.5% upside), with an analyst consensus of Buy.

The SYNH short-term stock prediction for tomorrow is $42.96 (-0.05%). The SYNH stock price prediction for 2027 estimates an average of $44. The SYNH stock prediction for 2030 projects a range of $44–$44.

Syneos Health, Inc. trades on NASDAQ under the ticker SYNH. The SYNH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

SYNH forecast · 8 questions

According to 24 Wall Street analysts, the average 12-month SYNH price target is $72.00, with a high forecast of $105.00 and a low of $25.00. The median price target is shown in the chart above when available. This implies +67.5% potential upside from the current price of $42.98.

SYNH price targetWhat is SYNH price targetSYNH analyst price targetSYNH 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.